| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |